PEPID Achieves Meaningful Use Stage 2 Certification
March 24, 2015 — PEPID has announced its leading drug interaction checker and drug allergy checker are now certified to help eligible hospitals and providers achieve the Stage 2 meaningful use measures under the American Reinvestment and Recovery Act (ARRA). When employed as a module within any electronic health record system (EHR), PEPID’s drug interaction checker can cross reference any combination of a patient’s medications and alternative medicines and alert the provider if